Skip to main content

TriSalus Life Sciences, Inc.

TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001826667

In the last 90 days, TriSalus Life Sciences, Inc. insiders filed 1 open-market purchase and 3 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.

Other share classesTLSIW

Key figures

Market capClose on Nov 17, 2026
$141.6M
Insider buysLast 90 days, $112.0K in total
1
Insider sellsLast 90 days, $4.11K in total
3
13F holdersQ2 2026, −4 vs. previous quarter
78
13F valueReported value at the end of Q2 2026
$99.0M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$45.2M
+53.4% year over year
Net income, FY2025
-$39.2M
No comparable prior period
Free cash flow, FY2025
-$18.9M
No comparable prior period
Revenue, Q3 FY2026
$12.9M
+11.3% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $39.2M (86.9% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
3.31M
Shares sold short
Change
−132.3K
−3.8% vs. previous
Days to cover
28.45
At average daily volume

Superinvestors holding TLSI, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding TLSI at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by TriSalus Life Sciences, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)8:16 AM ETNov 124 daysWahlstrom MatsDirectorPPurchase+50.0K$2.24+$112.0K+33.9%197.6K after
Oct 7, 2026 (view filing)4:02 PM ETOct 52 daysCox Bryan F.Chief of ResearchSSale−296$4.39−$1.30K−0.2%162.8K after
Oct 7, 2026 (view filing)4:02 PM ETOct 52 daysMarshak RichardChief Commercial OfficerSSale−325$4.39−$1.43K−0.3%128.0K after
Oct 7, 2026 (view filing)4:02 PM ETOct 52 daysStevens JenniferChief Regulatory OfficerSSale−316$4.39−$1.39K−0.3%123.8K after
May 19, 2026 (view filing)May 154 daysMarshak RichardChief Commercial OfficerSSale−543$2.67−$1.45K−0.4%125.1K after
May 18, 2026 (view filing)May 153 daysWahlstrom MatsDirectorPPurchase+60.0K$2.53+$151.8K+68.5%147.6K after
May 18, 2026 (view filing)May 153 daysStansky Michael PDirectorPPurchase+410.0K$2.50+$1.02M+49.4%1.24M after
May 18, 2026 (view filing)May 153 daysStansky Michael PDirectorPPurchase+200.0K$2.50+$500.0K+100.2%399.7K after
May 18, 2026 (view filing)May 153 daysSzela Mary TCEO and PresidentPPurchase+39.7K$2.59+$102.8K+3.9%1.07M after
May 18, 2026 (view filing)May 153 daysPatience DavidChief Financial OfficerPPurchase+7.10K$2.43+$17.3K+2.6%275.8K after

Top 10 13F holders, Q2 2026

See all 78 holders

The largest institutional positions in TriSalus Life Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding TLSI in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
First Light Asset Management, LLC6,552,491$29.8M1.81%+1,485,664+29.3%Added
BlackRock, Inc.2,659,218$12.1M0.00%+1,159,671+77.3%Added
Vanguard Capital Management LLC1,729,385$7.87M0.00%+382,349+28.4%Added
Cerity Partners LLC1,603,538$7.30M0.01%+816,266+103.7%Added
Geode Capital Management, LLC1,190,067$5.42M0.00%+412,973+53.1%Added
Nantahala Capital Management, LLC1,000,000$4.55M0.27%−1,070,827−51.7%Reduced
Gilder Gagnon Howe & Co LLC850,081$3.87M0.04%−38,434−4.3%Reduced
State Street Corp610,963$2.78M0.00%+282,943+86.3%Added
White Pine Capital LLC547,577$2.49M0.59%+347,732+174.0%Added
Thompson Siegel & Walmsley LLC536,534$2.44M0.04%−47,040−8.1%Reduced

Holders of 5% or more of TLSI

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of TriSalus Life Sciences, Inc..

Largest holders of TLSI from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Frankenius Equity AB13D/A14.00%6.99M shares−6.50 ppfrom 20.50%Aug 21, 20234 filingsAug 4, 2025SEC
First Light Asset Management, LLC13G/A12.00%7.41M shares+1.26 ppfrom 10.74%May 15, 20263 filingsNov 16, 2026SEC
Wahlstrom Mats13D/A6.00%2.99M shares−3.00 ppfrom 9.00%Aug 21, 20233 filingsAug 1, 2025SEC
Utmost Group Plc13G5.71%3.50M shares−1.08 ppfrom 6.79%Aug 18, 20253 filingsMay 12, 2026SEC
Pallotta James J13G/A5.20%3.19M shares–Dec 4, 20242 filingsMay 20, 2026SEC